I've registered if only for a laugh.....18 Mar 2026 08:45
Like the header says, I've registered and submitted the following questions. I'm not expecting any of them to be addressed......
- In previous announcements, mention was made of discussions with a number of top 10 global pharma. The latest RNS makes no mention of this. Are discussions continuing with 1 or more top 10 global pharma?
- When Tim said that a deal would be completed in 2025, what grounds were there for such optimism considering that deals for platform drugs often take 6-12 months?
- Why in interviews does Tim never address directly the concerns of shareholders, such as the latest dilution and only supplies platitudes like 'Keep the faith'?
- Seeing how Tim communicated in the Proactive interview that Lanstead Capital approached Immupharma regarding investing, who is deciding on Immupharma strategy, the BoD or Lanstead Capital
- Despite saying that shareholder value is important to Tim, why does Immupharma keep using Lanstead Capital who have a track record of suppressing the share price by selling into the market on price rises?
- Would Immupharma be better served at this stage by a new CEO?
GLA genuine LTH's!